Compounds > aromasil

Page last updated: 2024-08-24

aromasil and Menopause

aromasil has been researched along with Menopause in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Chen, G; Goss, P; Ho, V; Lazarus, P; Luo, S; Pasquet, R; Richardson, H; Tu, D	1
Cottu, P; Donnadieu, A; Leman-Detours, S; Saltel-Fulero, A	1
Chlebowski, R; Goss, P; Maunsell, E; Meggetto, O; Richardson, H; Tu, D	1
de Cremoux, P; Diéras, V; Fourquet, A; Magdelénat, H; Pierga, JY; Poupon, MF; Sigal-Zafrani, B	1
Delozier, T; Khayat, D; Spano, JP	1
Abreu, P; Banke-Bochita, J; Goss, PE; Hadji, P; Subar, M; Thomsen, T	1
Asmar, L; Blum, JL; Bordelon, JH; Brooks, R; Cantrell, J; Chittoor, S; Davis, JC; Hartung, NL; Holmes, FA; Ilegbodu, D; Jones, SE; Ketchel, SJ; Kochis, J; Negron, AG; O'Shaughnessy, J; Pippen, J; Richards, DA; Rivera, R; Vukelja, S; Whittaker, TL	1
Benedetti, MS; Coombes, RC; Di Salle, E; Evans, TR; Lassus, M; Ornati, G; Pianezzola, E	1

Reviews

3 review(s) available for aromasil and Menopause

Article	Year
[New options in adjuvant endocrine therapy in breast cancer]. Bulletin du cancer, 2016, Volume: 103, Issue:1 Topics: Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Estrogen Antagonists; Estrogens; Female; Humans; Menopause; Receptors, Estrogen; Tamoxifen; Time Factors	2016
[Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects]. Bulletin du cancer, 2004, Volume: 91, Issue:12 Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Letrozole; Menopause; Neoplasms, Hormone-Dependent; Nitriles; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles	2004
[Aromatase inhibitors in adjuvant setting in breast cancer]. Bulletin du cancer, 2004, Dec-01, Volume: 91 Suppl 4 Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Menopause; Nitriles; Triazoles	2004

Trials

4 trial(s) available for aromasil and Menopause

Article	Year
Factors Associated With Early Discontinuation of Study Treatment in the Mammary Prevention.3 Breast Cancer Chemoprevention Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Feb-20, Volume: 35, Issue:6 Topics: Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Chemoprevention; Female; Humans; Menopause; Middle Aged; Patient Compliance; Patient Dropouts; Quality of Life; Surveys and Questionnaires	2017
Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women. Breast cancer research : BCR, 2007, Volume: 9, Issue:4 Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Bone Density; Bone Remodeling; Bone Resorption; Breast Neoplasms; Estrogens; Female; Humans; Letrozole; Lipids; Menopause; Middle Aged; Nitriles; Peptide Fragments; Placebos; Procollagen; Single-Blind Method; Tamoxifen; Triazoles	2007
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Oct-20, Volume: 25, Issue:30 Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Follow-Up Studies; Hot Flashes; Humans; Menopause; Middle Aged; Quality of Life; Surveys and Questionnaires; Tamoxifen; Time Factors; Treatment Outcome	2007
Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women. Cancer research, 1992, Nov-01, Volume: 52, Issue:21 Topics: Aged; Androstadienes; Androstenedione; Aromatase Inhibitors; Dehydroepiandrosterone; Estrogens; Female; Follicle Stimulating Hormone; Headache; Humans; Luteinizing Hormone; Menopause; Middle Aged; Testosterone	1992

Other Studies

1 other study(ies) available for aromasil and Menopause

Article	Year
Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial. Breast cancer research and treatment, 2020, Volume: 183, Issue:3 Topics: Androstadienes; Breast Neoplasms; Female; Genotype; Glucuronosyltransferase; Humans; Menopause; Minor Histocompatibility Antigens	2020